India, June 4 -- Shares of Merus N.V. (MRUS) slipped over 7% on Wednesday morning after the oncology company priced an offering of 5 million shares at $57 a share.
MRUS is currently trading at $57.57, down $4.85 or 7.77%, on the Nasdaq. The stock opened its trading at $58.12 after closing Tuesday at $62.42. The stock has traded between $33.19 and $62.98 in the past 52-week period.
The company announced the pricing of an underwritten public offering of 5.26 million shares at a public offering price of $57.00 per share. The offering is expected to close on or about June 5, 2025.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
The gross proceeds from the offering are expected to be about $300.0 million....